-- 
Abbott Bonds Fall After Drugmaker Plans Divide, Trace Data Show

-- B y   P i e r r e   P a u l d e n
-- 
2011-10-19T14:33:34Z

-- http://www.bloomberg.com/news/2011-10-19/abbott-bonds-fall-after-drugmaker-plans-divide-trace-data-show.html
Bonds of  Abbott Laboratories (ABT)  fell
after the maker of  infant formula , heart stents and prescription
drugs said it will split into two companies.  Abbottâ€™s $1 billion of 4.125 percent notes due in May 2020
dropped 1.5 cents to 108.8 cents on the dollar at 10:19 New York
time, according to Trace, the bond-price reporting system of the
Financial Industry Regulatory Authority. The debt has decreased
from 112.3 cents on Sept. 22, Trace data show.  The Abbott park, Illinois-based firm will divide into two
publicly traded companies, with one focusing on generic drugs
and medical devices and the other research-based medicines, it
said today in a statement.  To contact the reporter on this story:
Pierre Paulden in New York at 
 ppaulden@bloomberg.net   To contact the editor responsible for this story:
Pierre Paulden at 
 ppaulden@bloomberg.net  